Zim Laboratories Ltd.

Financial

	Zim Laboratories	Medicamen Biotech	Albert David
Operational Metrics
Pharmaceutical Sector
R&D as a % of Total Sales	7.0 %	n/a	0.84 %
Financials
5 yr Average ROE	7.41 %	8.49 %	11.47 %
5yr average Equity Multiplier	1.88	1.47	1.63
5yr Average Asset Turnover Ratio	0.94	0.58	0.62
5yr Avg Net Profit Margin	4.15 %	10.0 %	11.31 %
Price to Book	2.09	2.45	1.27
P/E	43.2	73.38	28.98
5yr Avg Cash Conversion Cycle	37.07 Days	13.14 Days	-77.77 Days
Inventory Days	68.72 Days	66.66 Days	47.91 Days
Days Receivable	99.71 Days	122.66 Days	27.87 Days
Days Payable	143.26 Days	257.34 Days	140.35 Days
5yr Average Interest Coverage Ratio	3.96	10.36	93.73
5yr Avg ROCE	13.52 %	12.12 %	14.69 %
5yr Avg Operating Profit Margin	12.21 %	16.84 %	9.55 %
5 yr average Debt to Equity	0.39	0.14	0.02
5yr CAGR Net Profit	10.7 %	-6.51 %	-4.92 %
5yr Average Return on Assets	4.02 %	5.75 %	7.03 %
Shareholdings
Promoter Holding	33.26 %	40.46 %	62.24 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-3.14 %	0.25 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Zim Laboratories	Medicamen Biotech	Albert David
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Pharmaceuticals Formulations 0 Pharmaceuticals 0	Product Wise Break-Up Pharmaceutical 0 Pharmaceuticals Formulations 100.0 Pharmaceuticals 0	Product Wise Break-Up Pharmaceutical 0 Pharmaceuticals Formulations 0 Pharmaceutical 100.0
Location Wise Break-Up	Location Wise Break-Up Middle East 39.0 Asia (Ex India) 25.0 India 17.0 Africa 9.0 Rest of the World 0 Others 10.0	Location Wise Break-Up India 20.0 Asia (Ex India) 0 Rest of the World 0 Africa 0 Middle East 0 Others 80.0	Location Wise Break-Up India 93.24 Asia (Ex India) 0 Rest of the World 6.76 Africa 0 Middle East 0
Capex	Capex India 83.34 Others 16.66	-	-
Customer Segment	Customer Segment Export 81.0 Government 16.0 Deemed Export 3.0	-	-
Asset Break-Up	Asset Break-Up India 89.38 Others 10.62	-	-